[Preoperative radiotherapy in rectal cancer]

Area of Science:

• Oncology
• Radiation Oncology
• Surgical Oncology

Background:

• Rectal carcinoma presents a significant challenge in cancer treatment.
• Combined modality treatments are continuously explored to improve patient outcomes.
• The role of neoadjuvant therapy in rectal cancer management requires ongoing investigation.

Purpose of the Study:

• To evaluate the efficacy of preoperative irradiation in rectal carcinoma.
• To compare outcomes between combined preoperative irradiation and surgery versus surgery alone for rectal cancer.
• To assess the impact of neoadjuvant radiotherapy on tumor-related mortality and side effects.

Main Methods:

• A randomized clinical trial was conducted between 1973 and 1980.
• Patients with rectal carcinoma were randomized to receive either preoperative irradiation (34.5 Gy) followed by surgery or surgery alone.
• Irradiation was delivered using Cobalt-60 with opposing fields, encompassing the pelvis and para-aortal region.

Main Results:

• The study evaluation in March 1983 revealed a significantly higher incidence of tumor-related deaths in the surgery-only group.
• Preoperative irradiation demonstrated a survival benefit by reducing cancer-specific mortality.
• No substantial differences in the occurrence of side effects were noted between the preirradiated and non-preirradiated groups.

Conclusions:

• Preoperative irradiation is a beneficial addition to surgical management for rectal carcinoma.
• Combined therapy improves survival outcomes by reducing tumor-related deaths.
• The addition of preoperative irradiation does not significantly increase treatment-related morbidity.